期刊
NATURE BIOTECHNOLOGY
卷 38, 期 7, 页码 824-844出版社
NATURE PORTFOLIO
DOI: 10.1038/s41587-020-0561-9
关键词
-
资金
- Merkin Institute of Transformative Technologies in Healthcare
- US NIH [U01AI142756, RM1HG009490, R01EB022376, R35GM118062]
- HHMI
- Jane Coffin Childs postdoctoral fellowship
- NSF
A growing arsenal of CRISPR-based tools enables increasingly sophisticated genome editing applications. The development of new CRISPR-Cas genome editing tools continues to drive major advances in the life sciences. Four classes of CRISPR-Cas-derived genome editing agents-nucleases, base editors, transposases/recombinases and prime editors-are currently available for modifying genomes in experimental systems. Some of these agents have also moved rapidly into the clinic. Each tool comes with its own capabilities and limitations, and major efforts have broadened their editing capabilities, expanded their targeting scope and improved editing specificity. We analyze key considerations when choosing genome editing agents and identify opportunities for future improvements and applications in basic research and therapeutics.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据